Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,175 | 16,634 | 1,417 | 3,821 | 563 |
| Marketable Securities | 8,497 | 13,207 | N/A | N/A | N/A |
| Receivables | 436 | 439 | 192 | 414 | 321 |
| Other current assets | 0 | 3 | 2 | 0 | 0 |
| TOTAL | $50,873 | $30,395 | $1,645 | $4,269 | $884 |
| Non-Current Assets | |||||
| PPE Net | 3 | 14 | 6 | 6 | 1 |
| Investments And Advances | 0 | 31 | 31 | N/A | N/A |
| Intangibles | 0 | 2,952 | 2,885 | 5,596 | 0 |
| TOTAL | $3 | $2,997 | $2,922 | $5,602 | $1 |
| Total Assets | $50,876 | $33,392 | $4,567 | $9,871 | $886 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,068 | 784 | 1,080 | 885 | 101 |
| Accrued Expenses | 1,524 | 1,948 | 1,005 | 765 | 72 |
| TOTAL | $3,592 | $2,732 | $2,085 | $1,650 | $172 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 857 |
| TOTAL | $0 | $0 | $0 | $0 | $857 |
| Total Liabilities | $3,592 | $2,732 | $2,085 | $1,650 | $1,030 |
| Shareholders' Equity | |||||
| Common Shares | 73,669 | 46,673 | 22,258 | 22,208 | 3,415 |
| Retained earnings | -52,677 | -35,807 | -23,293 | -15,914 | -3,753 |
| Other shareholders' equity | 19,095 | 16,012 | 1,546 | -1 | 0 |
| TOTAL | $47,284 | $30,660 | $2,482 | $8,221 | $-144 |
| Total Liabilities And Equity | $50,876 | $33,392 | $4,567 | $9,871 | $886 |